Fucoidan/chitosan nanoparticles functionalized with anti-ErbB-2 target breast cancer cells and impair tumor growth in vivo

Catarina Oliveira; Céline S. Gonçalves; Eduarda P. Martins; Nuno M. Neves; Rui L Reis; Bruno M. Costa; Tiago H. Silva; Albino Martins

doi:10.1016/j.ijpharm.2021.120548

Related publications

Article2018

Gemcitabine Delivered by Fucoidan/Chitosan Nanoparticles Presents Increased Toxicity Over Human Breast Cancer Cells

Catarina Oliveira, Nuno M. Neves, Rui L Reis, Albino Martins, Tiago H. Silva

Article2019

Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo

Catarina Oliveira, Sara Granja, Nuno M. Neves, Rui L Reis, Fátima Baltazar, Tiago H. Silva, Albino Martins

Article2019

Elucidating the Inability of Functionalized Nanoparticles to Cross the Blood–Brain Barrier and Target Specific Cells in Vivo

Priya S. R. Naidu, Nikolas Gavriel, Chloe G. G. Gray, Carole A. Bartlett, Lillian M. Toomey, Jessica A. Kretzmann, Diana Patalwala, Terence McGonigle, Eleanor M Denham, Charmaine Hee, Diwei Ho, Nic Taylor, Marck Nörret, Nicole M. Smith, Sarah A. Dunlop, K. Swaminathan Iyer, Melinda Fitzgerald

Article2022

Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles

Leila Mohammad Gholinia Sarpoli, Shohreh Zare Karizi, Erfan Heidari, Akbar Hasanzadeh, Mehrdad Bayandori, Fereshteh Azedi, Michael R Hamblin, Mahdi Karimi

Preprint2023

Tumor sialylation is a barrier against CD8 T cell-mediated anti-tumor responses and anti-PD-1 resistance in breast cancer

Stefan Mereiter, Gustav Jonsson, Tiago Oliveira, Johannes Helm, David Hoffmann, Markus Abeln, Ann-Kristin Jochum, Wolfram Jochum, Max J. Kellner, Marek Feith, Vanessa Tkalec, Karolina Wasilewska, Jie Jiao, Lukas Emsenhuber, Felix Holstein, Anna C. Obenauf, Leonardo Lordello, Jean–Yves Scoazec, Guido Guido Kroemer, Laurence Zitvogel, Omar Hasan Ali, Lukas Flatz, Rita Gerardy‐Schahn,